An advocacy roadmap to recognition and payment for pharmacist patient-care services
December 15, 2025
In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Anna Legreid Dopp, PharmD, CPHQ is senior director, government relations at ASHP where she works on state and national policy efforts in the Office of Government Relations. In her 10 years at ASHP she has served as the staff secretary of the Council on Pharmacy Practice and worked in the Office of Practice Advancement on clinical guidelines and national quality initiatives.
Tom Kraus, JD, MHS serves as the chief advocacy officer and vice president of government relations for ASHP. Kraus previously served as the deputy staff director of health on the U.S. Senate Committee on Health, Education, Labor and Pensions under Senators Edward Kennedy and Tom Harkin, where he was instrumental in the passage of key legislation, including Food and Drug Administration (FDA) drug and food safety reforms and user fee legislation, the American Recovery and Reinvestment Act, and the Affordable Care Act. Following his time on Capitol Hill, he joined the FDA, where he served as Chief of Staff and Associate FDA Commissioner for Legislation.
Daniel J. Cobaugh, PharmD, FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT